← All claims

Metabolic & Cardiometabolic

resistant starch decreases postprandial glucose

In plain terms: Does resistant starch lower blood sugar after a meal?

Strong support Metabolic & Cardiometabolic 🔬 Includes disconfirming⚠️ Includes retracted (not counted)

Part of: 🧪 resistant starch

RefutedContestedStrong support
consensus score 0.65

Yes for the post-meal spike, but its longer-term fasting effect is small and needs fairly large daily doses.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

16 support 1 contradict 1 tested null 2 mixed · 20 sources, 17 independent groups · 1 retracted, not counted

What the evidence shows

Resistant starch (esp. high-amylose wheat RS2) lowers the acute postprandial glucose/insulin response; chronic fasting-glucose effect is small and dose-hungry (>28 g/d).

The evidence (24)

SourceGradeStanceQualityFinding
Pugh JE, Cai M, Altieri N, Frost G
2023 · Front Nutr
meta-analysis supports high Meta-analysis in T2D/prediabetes: resistant starch types 1 and 2 lowered acute postprandial glucose (SMDs -0.38 and -0.29); RS2 improved acute response.
Sandberg JC, Björck IME, Nilsson AC
2017 · Nutrition Journal
RCT supports moderate Whole-grain rye with RS2 supplementation improved glucose tolerance and gut-hormone responses over an extended postprandial window in healthy subjects.
Tian J, Wang N, Song C, Kong F, Wen C, Jiang Z, Song S
2026 · Foods (Basel, Switzerland)
animal supports low In vivo rice-starch gel model; Ca2+-alginate crosslinking raised RS 7.7%->14.4%; postprandial iAUC fell 747.2->591.7 mmolmin/L (p<0.05) vs uncrosslinked RS gel.
Itkonen ST, Chapelais M, Calvez J, Airinei G, Benamouzig R, Pajari AM, Gaudichon C
2025 · Food Res Int
observational mixed moderate Ileal starch digestibility study: faba-bean resistant starch only partly explained the lower postprandial glycemic response in healthy humans.
Xiong K, Wang J, Kang T, Xu F, Ma A
2021 · Br J Nutr
meta-analysis supports moderate Fasting glucose -0.09 mmol/L (-0.16 at >28 g/d); HOMA-IR -0.33; fasting insulin NS
Gourineni V, Stewart ML, Wilcox ML, Maki KC
2020 · Foods
RCT supports moderate Nutritional bar with potato-based resistant starch attenuated postprandial glucose and insulin responses vs control in healthy adults.
Lee CM, Jeong OY, Park HS, Seo J, Park S, Lee KM, Jin M, Choi IR, Han JH
2025 · Frontiers in plant science
animal supports low 16 Korean rice accessions; high-RS/SDS lines (Seullomi1/2, Dodamssal) had lower in vitro GI (<60) and, in mice (n=5/group), significantly reduced blood glucose spikes at 30 min vs commercial rice.
Collins SM, Bernadette Egan M, Whyte MB, Denise Robertson M
2025 · Diabetic Medicine
RCT supports moderate Partial substitution of dietary starch with resistant starch lowered postprandial glucose and glycemic variability (MAGE) in people with type 2 diabetes.
Duan Y, Hou L, Bi J, Xiao S, Zhang Y, Zhan W, Du J, Ding W, Wu Y, Wang X
2026 · International journal of biological macromolecules
animal supports low Hyperglycemic Drosophila (T2DM model); WS-MA complex (RS5) 45% replacement vs sucrose/corn-flour control: blood glucose -46%, triglycerides -27%.
Corrado M, Savva GM, Ahn-Jarvis JH, Oyeyinka SA, Edwards CH, Hazard BA
2025 · Food & function
RCT contradicts high Human RCT (n=26), CGM, crossover: high-amylose (sbeII mutant, RS-enriched) bread vs isoglucidic WT bread. Max 2h glucose rise: -0.08+/-0.12 mmol/L difference, p=0.514 (null), despite ~7% lower in vitro digestibility (p=0.006).
Dainty SA, Klingel SL, Pilkey SE, McDonald E, McKeown B, Emes MJ, Duncan AM
2016 · J Nutr
RCT contradicts moderate Randomised double-blind crossover, n=24 adults at increased T2D risk (mean age 55, BMI 30): 25 g/d HAM-RS2 (high-amylose maize) bagel vs control wheat bagel for 56 d each. Outcome was a 75 g OGTT on days 1 and 57, not the acute response to an RS food: 'Fasting and postprandial OGTT glucose concentrations did not differ between the RS and control bagel treatments on study days 1 or 57.' Insulin iAUC 2-h -23.3% (P<0.008), HOMA-IR -23.1% (P=0.04). Abstract-only.
Su&#xe1;rez-Di&#xe9;guez T, Olvera N&#xe1;jera M, Silva M, L&#xf3;pez-Rodr&#xed;guez G, Ariza-Ortega JA, Garc&#xed;a-Tejedor A, Nieto JA
2025 · Nutrients
animal supports low Diabetic Wistar rats; faba-bean retrograded RS (15/30% diet replacement) vs untreated diabetic controls: postprandial hyperglycemia attenuated ~29% (24.56/25.02 vs 34.65 mmol/L); fasting glucose -22%.
Wei J, Fan Z, Deng Y, Pan K, Shi R, Hu J, Liu B
2026 · Nutrients
RCT supports moderate Minimally cooked (high-RS) potato improved glycemic response across two meals and insulin sensitivity of rice-potato mixed meals in an acute RCT.
Abdi SAH, Abdi SIA, Ali MH, Balani NA, Balani NA, Jacob HL, Seyfi A, Al Shabout GH, Hamza DN, Al-Talabani AD, Khan R
2025 · Cureus
observational supports low Systematic review of RCTs: dietary fiber interventions including resistant starch improved glycemic control in diabetes.
⚠️ RETRACTED — not counted
Zeng J, Li P, Chen H, Li F, He X, Liu G, Zhou P, Zhao Z, Zhang Y, Zhang M, Deng Y
2026 · NPJ science of food
animal supports low High-fat-diet diabetic mice, 6-wk feeding; two resistant-starch-rich rice varieties (RSRR) vs common rice: reduced fasting glucose, blood lipids, and postprandial glucose response (KTD variety most effective).
Tavares IRG, do Carmo E&#xc9;A, da Silveira Alvares T
2026 · Curr Nutr Rep
observational supports low Integrative review: resistant starch consistently associated with improved postprandial glucose and cardiometabolic risk markers in human trials.
Peng X, Fan Z, Wei J, Liu R, Lou X, Hu J, Xing Y
2024 · Nutrients
RCT mixed moderate Cold-stored (retrograded, higher-RS) millet did NOT outperform fresh-cooked for second-meal glycemia; RS content alone did not predict the effect.
Siminiuc R, Vîrlan A
2026 · Foods
RCT supports moderate Human crossover, n=10 healthy adults (20-35 y, normal BMI), ISO 26642 GI: 83.03 +/- 15.02 freshly cooked vs 43.55 +/- 6.99 after 2160 h at -18 C; repeated-measures ANOVA p<0.0001, every condition except 6 h at 20 C significant vs fresh; the 4 C arm reached 53.86 at 120 h. RS 1.78% -> 3.98% is a SEPARATE in-vitro assay (n=3 per condition), and r=-0.935 (R2=0.8735) is a Pearson correlation across the NINE condition means, not across participants. Storage regime, not resistant starch, was the assigned exposure.
Di Rosa C, De Arcangelis E, Vitelli V, Crucill&#xe0; S, Angelicola M, Trivisonno MC, Sestili F, Blasi E, Cicatiello C, Lafiandra D, Masci S, Messia MC, De Gara L, Marconi E, Khazrai YM
2023 · Nutrients
RCT supports low HA bread/biscuits (~12% starch as RS) significantly lower GI; n=10
Xu F, Wang Y, Li H, Xu G, Jiang W, Li M, Dai L, Wang X, Xu B
2026 · International journal of biological macromolecules
animal supports low C57 mice; PS-HTPs complex (peptide-modified potato starch, RS +23.28%, SDS +5.25%) vs native potato starch: peak blood glucose -42.0%. Acute single-meal, food-engineering model.
Belobrajdic DP, Regina A, Klingner B, Zajac I, Chapron S, Berbezy P, Bird AR
2019 · Nutrients
RCT supports moderate High-amylose wheat bread lowered postprandial glycemic response vs conventional
Steele TJ, Maningat CC, Seib PA, Haub MD, Rosenkranz SK
2021 · Curr Dev Nutr
RCT tested-null moderate Resistant wheat starch type 4 vs native wheat starch: glucose attenuation depended on testing protocol/food matrix, not uniform across conditions.
Maiya M, Adorno A, Toulabi SB, Tucker WJ, Patterson MA
2023 · Nutrition Research
observational supports low Narrative review of randomized trials: resistant starch improved cardiometabolic outcomes including postprandial glucose/insulin handling.
Liu J, Meng Y, Ma A, Chang R
2025 · NPJ science of food
animal supports low Mice; bionic grain-resistant corn starch (RS 9.3%->22.6% via gellan-gum/soy-protein encapsulation) vs native corn starch: peak postprandial glucose 11.98->9.58 mmol/L.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.